Login
Related Links
Special News Items
- A New Gene Therapy Technique Aims to Deliver Treatment Before Birth
- Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials
- ISCT Becomes the First Cell and Gene Therapy Organization to Achieve ANAB Accreditation for Workforce Development
- First patient dosed in uniQure trial of AMT-191 gene therapy for Fabry
- Researchers say gene therapy breakthrough shows promise for glaucoma
- Switching Gene Therapy On and Off with a Pill
- Toddler Born Deaf Can Hear After Gene Therapy Trial Breakthrough Her Parents Call "Mind-Blowing"
- First Patient Begins Newly Approved Sickle Cell Gene Therapy
- FDA approves Orchard’s Lenmeldy gene therapy for MLD
- Team performs the first gene therapy tests in a whole human liver
- Gene Therapy Success in Hereditary Angioedema Patients
- FDA Approves CRISPR Gene Therapy to Treat Blood Disorder
- FDA Signals Imminent Approval for Sarepta’s Duchenne Gene Therapy: A Major Breakthrough for Patients
- Revolutionary gene therapy shows promise in treating autism
- Cell & Gene Therapy Space Gears Up for First CRISPR Approval
- Gene therapy restores hearing in children with rare form of deafness
- UK biotech AlveoGene launches with plans for inhaled gene therapy
- Gene Therapy Targets Chronic Pain
- Gene therapy eyedrops restored a boy's sight. Similar treatments could help millions
- Gene therapy approved by FDA for certain boys with rare genetic condition
- FDA Needs More Cell, Gene Therapy Mid Managers to Speed Reviews
- Biology Professor Venigalla Rao Makes Breakthrough on Gene Therapy Research
- Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS)
- Bacterial ‘Nanosyringe’ Could Deliver Gene Therapy to Human Cells
- EU approves Hemgenix, one-time gene therapy for hemophilia B
- FDA officials offer advice on gene therapy trials
- New gene therapy delivers treatment directly to brain
- FDA approves Ferring’s Adstiladrin as first gene therapy for bladder cancer
- FDA Approves First Gene Therapy for Hemophilia B
- FDA finalizes neurodegenerative disease gene therapy guidance